Therapeutics

Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time

8 days ago   |   By San Diego Biotechnology

SAN DIEGO, Feb. 13, 2020 - Obalon Therapeutics, Inc. , a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces th......
Read more ...

 

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

8 days ago   |   By Xconomy

Eisai is withdrawing weight-loss drug lorcaserin after a post-marketing study found a higher incidence of cancer in patients who took the medicine. The FDA said Thursday that its request for removal of the product from the market is voluntary, but Eisai has already started the process for doing so. The withdrawal follows an FDA alert issued last month that lorcaserin may contribute to a higher risk of cancer. Lorcaserin was approved in 2012 as a weight management therapy for use in addition to a reduced-calorie diet and exercise. The drug was intended to suppress appetite while avoiding...
Read more ...

 


Search by Tags

   Therapeutics      Obesity      Gas      News      Syndication      Nasdaq      OBLNUS67424L1008      Therapies      Drugs      Cancer      Drug      Medicine      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Europe blog main      Europe top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      Arena Pharmaceuticals      Biotech      Cancer      Cardiovascular Disease      Clinical trials      Colorectal Cancer      Eisai      FDA      Life Sciences      Lorcaserin      Lung Cancer      Obsesity      Orexigen Therapeutics      Pancreatic Cancer      Product recalls      Vivus  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin... Read more ...

MyoNet: A Transfer-learning based LRCN for Lower Limb Movement Recognition...

MyoNet: A Transfer-learning based LRCN for Lower Limb Movement Recognition and Knee Joint Angle Prediction for Remote Monitoring of Rehabilitation Progress from sEMG

The clinical assessment technology such as remote monitoring of rehabilitation progress for lower limb related ailments rely on the automatic evaluation of movement performed... Read more ...

Feasibility of using high-contrast grating as a point-of-care sensor for...

Feasibility of using high-contrast grating as a point-of-care sensor for therapeutic drug monitoring of immunosuppressants

Abstract Point-of-care testing has demonstrated great transformative potential in personalized medicine. In particular, patients undergoing transplantation require POC testing... Read more ...

Development Of Low-Cost Point-Of-Care Technologies For Cervical Cancer...

Development Of Low-Cost Point-Of-Care Technologies For Cervical Cancer Prevention Based On A Single-Board Computer

Cervical cancer disproportionally affects women in low- and middle-income countries, in part due to the difficulty of implementing existing cervical cancer screening and... Read more ...

SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal

SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal

Since a major restructuring at Five Prime Therapeutics in October that kicked off a wind-down of most of its research and preclinical efforts, the company has been looking to... Read more ...

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

Spruce Biosciences has raised $88 million to advance clinical testing of a drug for a rare inherited endocrine disorder that can lead to a potentially life-threatening hormonal... Read more ...

COVID-19 Vaccine Will Close in on the Spikes

COVID-19 Vaccine Will Close in on the Spikes

As epidemiologists try to stay ahead of the spread of new coronavirus COVID-19, vaccine developers, like Sanofi and Johnson & Johnson , are focusing on the “spike” proteins... Read more ...

Brain cells protect muscles from wasting away

Several processes in the roundworm C. elegans boost the stress response in cells, incidentally making worms resistant to a high-fat diet and extending their lifespan... Read more ...

103967 Laboratory Research Assistant

PSYCHIATRY/HNRP Salary commensurate with qualifications and experienceFiling Deadline: Fri 3/6/2020... Read more ...

Sorrento Therapeutics CEO Dr. Ji to Present at LEERINK Partners 9th Global...

SAN DIEGO, Feb. 21, 2020 - Sorrento Therapeutics, Inc. , announced today that it will present at LEERINK Partners 9th Annual Global Healthcare Conference on Thursday...... Read more ...